Skip to content

Identification of Sodium Channel Fragments as Serum Biomarkers of a Traumatic Central Nervous System Injury

Identification Des Fragments de Canaux Sodiques Comme Biomarqueurs sériques d'Une lésion Traumatique du système Nerveux Central

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06532760
Acronym
SpasT-SCI-T
Enrollment
40
Registered
2024-08-01
Start date
2024-10-01
Completion date
2027-04-01
Last updated
2024-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries, Spasticity, Muscle, Spinal Cord Injury

Brief summary

Following spinal cord injury (SCI), 75% of patients develop spasticity of the limbs characterized by an increase in muscle tone causing severe pain. Currently, the diagnosis of spinal cord injury is based on clinical and radiological evaluation by CT and MRI, but there is no reliable biomarker capable of predicting the medium and long-term clinical course in terms of emergence and severity of spasticity and neurological recovery. Recently, pre-clinical models in rats have shown the presence of protein fragments from a cleavage of sodium channels in spinal cords below the level of injury. Other studies have also shown the presence of these fragments in the brain following a head injury. These fragments would be potentially useful as a biomarker of the SCI. The detection of sodium fragments would be potentially useful as a biomarker of a lesion of the central nervous system (spinal cord or brain) and of the severity of the spasticity in patients suffering from SCI. The main objective of this study is to detect the presence of sodium fragments in blood samples from patients with SCI from or brain injury. The secondary objectives will be to study the post-lesional / injury kinetics of sodium fragments, to determine their diagnostic values in terms of the severity of the injury, and their prognostic values concerning the emergence of the spasticity in patients with SCI. An initial prospective cohort will include 40 people. The fragments of sodium channels will be measured in blood samples taken within 6 hours post-trauma, then 1, 3, 5 and 7 days post-trauma, as well as 3 and 6 months post-trauma. The overall expression of sodium fragments will be compared to that of healthy controls. Participants will be recruited in the acute care units of the AP-HM. Participants will be recruited from the main acute care units of the AP-HM. Post-traumatic follow-up assessments during their rehabilitation will be carried out at 3 and 6 months in the neurosurgery department of North Hospital from APHM.

Interventions

OTHERBlood sampling

Blood sampling to study sodium fragment kinetics

Sponsors

Assistance Publique Hopitaux De Marseille
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

3 groups

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

healthy volonteers group: Inclusion Criteria * Male or Female * Age 18 to 75 * free of central or peripheral nervous system trauma * Having given free and informed consent * Beneficiary of or affiliated to a social security scheme

Exclusion criteria

* Pregnant or breast-feeding women * Person under guardianship or curatorship * Diagnosis of a neurological disorder * Diagnosis of a psychiatric disorder * Diagnosis of a neurodegenerative disease Spinal Cord injury patients group: Inclusion Criteria:- Male or female * Aged 18 to 75 * Beneficiary of or affiliated to a social security scheme * Having suffered within 6 hours a trauma with an acute LME confirmed according to the following characteristics: * Lesion located at C4-T12 level and radiologically documented (CT scan and/or spinal MRI performed within 6 hours) * Complete or incomplete according to the American Spinal Injury Association impairment scale (ASIA A to D) * Signed consent for emergency and continuation of study

Design outcomes

Primary

MeasureTime frame
Detect the presence of sodium fragments in blood samples from patients6 hours to 6 months post-injury

Secondary

MeasureTime frame
kinetics of sodium fragments in patients with acute SCI and in traumatic brain injury patients in the post-trauma period6 hours to 6 months post-injury
To correlate measurements of sodium fragments in blood from 6 hours to 6 months post-injury with the occurence of spasticity in the post-trauma period3 and 6 months-post-injury

Contacts

Primary ContactPierre-Hugues ROCHE
Pierre-hugues.ROCHE@ap-hm.fr0033491365135

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026